Back to top

medical-devices: Archive

Zacks Equity Research

Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing

AVTR collaborates with BlueWhale Bio to speed CAR-T manufacturing using CDNP tech, aiming to scale production and expand patient access.

MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change AVTRPositive Net Change

Santanu Roy

5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns

From Red Robin to Analog Devices, these five high-efficiency stocks stand out for their strong ratios and surprise earnings potential.

ADIPositive Net Change RRGBNegative Net Change ELMDNegative Net Change NCLHPositive Net Change TXGNegative Net Change

Indrajit Bandyopadhyay

Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?

Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.

BSXPositive Net Change ISRGPositive Net Change TMOPositive Net Change

Zacks Equity Research

WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?

West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.

MCKPositive Net Change EWPositive Net Change WSTPositive Net Change GMEDPositive Net Change

Moumi Mondal

CVS Expands Its Nationwide Care Network With Rite Aid Acquisition

CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.

UNHNegative Net Change CAHPositive Net Change CVSPositive Net Change

Zacks Equity Research

Is AMLX Stock a Solid Choice Right Now?

Amylyx has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

AMLXNegative Net Change

Zacks Equity Research

Reasons to Add HealthEquity Stock to Your Portfolio for Now

HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.

MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change HQYPositive Net Change

Kinjel Shah

J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan

J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.

JNJPositive Net Change MDTPositive Net Change SYKPositive Net Change KVUEPositive Net Change

Debanjana Dey

Hims & Hers Elevates Technology-Driven Healthcare Accessibility

HIMS boosts AI-led care with new technology chief, hormone therapies and a global push via its ZAVA acquisition.

TDOCNegative Net Change HIMSNegative Net Change TEMNegative Net Change

Moumi Mondal

Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?

CVS Health prepares Q3 results, with pharmacy performance and Aetna's progress in focus for investors.

UNHNegative Net Change CVSPositive Net Change ELVPositive Net Change

Zacks Equity Research

Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition

MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.

MASINegative Net Change MMSIPositive Net Change DRIONegative Net Change NDRANegative Net Change

Zacks Equity Research

GEHC Stock Up Following New Launch to Streamline Perinatal Workflow

GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.

RMDNegative Net Change HCAPositive Net Change GEHCPositive Net Change SOLVPositive Net Change

Zacks Equity Research

Reasons to Hold Veeva Systems Stock in Your Portfolio for Now

VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.

MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change VEEVNegative Net Change

Zacks Equity Research

Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs

ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.

ABTPositive Net Change PODDPositive Net Change PAHCPositive Net Change VCYTPositive Net Change

Zacks Equity Research

Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?

LH is poised for Q3 growth, with revenue and EPS estimates pointing higher as diagnostics and biopharma units deliver strong performances.

LHPositive Net Change IDXXNegative Net Change ANIPPositive Net Change EXASNegative Net Change

Indrajit Bandyopadhyay

Can Ion Emerge as ISRG's Vehicle to Tap Ambulatory Care Growth?

Intuitive Surgical's Ion platform gains traction in ambulatory centers, driving 52% growth as outpatient lung diagnostics accelerate.

BSXPositive Net Change BDXPositive Net Change ISRGPositive Net Change

Zacks Equity Research

Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now

WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.

CAHPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTPositive Net Change

Urmimala Biswas

NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings

NVDA and PLTR drive AI integration across healthcare, fueling optimism for Omnicell and Tempus AI's Q3 performance.

NVDAPositive Net Change OMCLNegative Net Change ORCLNegative Net Change PLTRPositive Net Change TEMNegative Net Change

Debanjana Dey

Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?

HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.

TDOCNegative Net Change AMWLNegative Net Change HIMSNegative Net Change

Zacks Equity Research

STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation

Stereotaxis partners with CardioFocus to commercialize the first robotic Pulsed Field Ablation system, aiming to revolutionize cardiac arrhythmia treatment.

MASINegative Net Change MMSIPositive Net Change STXSNegative Net Change WSTPositive Net Change

Zacks Equity Research

Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings

DGX is poised for solid Q3 2025 results, backed by strong DIS growth, strategic M&A and robust test demand across key health segments.

DGXPositive Net Change IDXXNegative Net Change ANIPPositive Net Change EXASNegative Net Change

Moumi Mondal

HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.

JNJPositive Net Change MDTPositive Net Change HOLXPositive Net Change